siRNA vs. shRNA: Similarities and differences

被引:454
作者
Rao, Donald D. [1 ]
Vorhies, John S. [1 ]
Senzer, Neil [1 ,2 ,3 ]
Nemunaitis, John [1 ,2 ,3 ]
机构
[1] Gradalis Inc, Dallas, TX USA
[2] Mary Crowley Canc Res Ctr, Dallas, TX USA
[3] Baylor Sammons Canc Ctr, Dallas, TX USA
关键词
RNA interference; Bi-functional; Cancer; Personalized; SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; ENDOTHELIAL GROWTH-FACTOR; INNATE IMMUNE-RESPONSE; IN-VIVO GROWTH; GENE-EXPRESSION; ANTISENSE OLIGONUCLEOTIDES; MICRORNA MATURATION; TUMOR-GROWTH; CHEMICAL-MODIFICATION;
D O I
10.1016/j.addr.2009.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
RNA interference (RNAi) is a natural process through which expression of a targeted gene can be knocked down with high specificity and selectivity. Using available technology and bioinformatics investigators will soon be able to identify relevant bio molecular tumor network hubs as potential key targets for knockdown approaches. Methods of mediating the RNAi effect involve small interfering RNA (siRNA), short hairpin RNA (shRNA) and bi-functional shRNA. The simplicity of siRNA manufacturing and transient nature of the effect per dose are optimally suited for certain medical disorders (i.e. viral injections). However, using the endogenous processing machinery, optimized shRNA constructs allow for high potency and sustainable effects using low copy numbers resulting in less off-target effects, particularly if embedded in a miRNA scaffold. Bi-functional design may further enhance potency and safety of RNAi-based therapeutics. Remaining challenges include tumor selective delivery vehicles and more complete evaluation of the scope and scale of off-target effects. This review will compare siRNA, shRNA and bi-functional shRNA. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:746 / 759
页数:14
相关论文
共 214 条
  • [1] Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
    Aharinejad, S
    Paulus, P
    Sioud, M
    Hofmann, M
    Zins, K
    Schäfer, R
    Stanley, ER
    Abraham, D
    [J]. CANCER RESEARCH, 2004, 64 (15) : 5378 - 5384
  • [2] Cellular Delivery In Vivo of siRNA-Based Therapeutics
    Aigner, A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (34) : 3603 - 3619
  • [3] Aigner A, 2007, CURR OPIN MOL THER, V9, P345
  • [4] Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA
    Akashi, H
    Miyagishi, M
    Yokota, T
    Watanabe, T
    Hino, T
    Nishina, K
    Kohara, M
    Taira, K
    [J]. MOLECULAR BIOSYSTEMS, 2005, 1 (5-6) : 382 - 390
  • [5] A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
    Akinc, Akin
    Zumbuehl, Andreas
    Goldberg, Michael
    Leshchiner, Elizaveta S.
    Busini, Valentina
    Hossain, Naushad
    Bacallado, Sergio A.
    Nguyen, David N.
    Fuller, Jason
    Alvarez, Rene
    Borodovsky, Anna
    Borland, Todd
    Constien, Rainer
    de Fougerolles, Antonin
    Dorkin, J. Robert
    Jayaprakash, K. Narayanannair
    Jayaraman, Muthusamy
    John, Matthias
    Koteliansky, Victor
    Manoharan, Muthiah
    Nechev, Lubomir
    Qin, June
    Racie, Timothy
    Raitcheva, Denitza
    Rajeev, Kallanthottathil G.
    Sah, Dinah W. Y.
    Soutschek, Juergen
    Toudjarska, Ivanka
    Vornlocher, Hans-Peter
    Zimmermann, Tracy S.
    Langer, Robert
    Anderson, Daniel G.
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (05) : 561 - 569
  • [6] Intracellular localization of lipoplexed siRNA in vascular endothelial cells of different mouse tissues
    Aleku, Manuela
    Fisch, Gerald
    Moepert, Kristin
    Keil, Oliver
    Arnold, Wolfgang
    Kaufmann, Joerg
    Santel, Ansgar
    [J]. MICROVASCULAR RESEARCH, 2008, 76 (01) : 31 - 41
  • [7] Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
    Aleku, Manuela
    Schulz, Petra
    Keil, Oliver
    Santel, Ansgar
    Schaeper, Ute
    Dieckhoff, Britta
    Janke, Oliver
    Endruschat, Jens
    Durieux, Birgit
    Roeder, Nadine
    Loeffler, Kathrin
    Lange, Christian
    Fechtner, Melanie
    Moepert, Kristin
    Fisch, Gerald
    Dames, Sibylle
    Arnold, Wolfgang
    Jochims, Karin
    Giese, Klaus
    Wiedenmann, Bertram
    Scholz, Arne
    Kaufmann, Joerg
    [J]. CANCER RESEARCH, 2008, 68 (23) : 9788 - 9798
  • [8] Anderson Emily, 2008, V442, P45, DOI 10.1007/978-1-59745-191-8_4
  • [9] [Anonymous], 2008, RNAi News, V6
  • [10] RNA interference may be more potent than antisense RNA in human cancer cell lines
    Aoki, Y
    Cioca, DP
    Oidaira, H
    Kamiya, J
    Kiyosawa, K
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (1-2) : 96 - 102